Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15071017rdf:typepubmed:Citationlld:pubmed
pubmed-article:15071017lifeskim:mentionsumls-concept:C0220847lld:lifeskim
pubmed-article:15071017lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:15071017lifeskim:mentionsumls-concept:C0556025lld:lifeskim
pubmed-article:15071017lifeskim:mentionsumls-concept:C0337910lld:lifeskim
pubmed-article:15071017lifeskim:mentionsumls-concept:C0444669lld:lifeskim
pubmed-article:15071017lifeskim:mentionsumls-concept:C0430420lld:lifeskim
pubmed-article:15071017pubmed:issue4lld:pubmed
pubmed-article:15071017pubmed:dateCreated2004-4-8lld:pubmed
pubmed-article:15071017pubmed:abstractTextWe evaluated a quantitative enzyme immunoassay (trak-C) for hepatitis C virus core antigen (HCV core Ag) by testing serum specimens from 820 injection drug users in Thailand with anti-HCV antibodies. The HCV genotypes in this population include genotypes 3 and 6, which have not been extensively tested with this assay. Among these specimens, 629 (76.7%) yielded positive results, with HCV core Ag concentrations predominantly spanning (35.7%) or above (58.2%) the measurable range of 1.5 to 100 pg/ml. To assess reproducibility, we retested 30 specimens representing six core Ag ranges; the mean coefficient of variation for each range was < or = 9.7% (highest for 1.5 to 25 pg/ml). We also tested 204 specimens of the 820-specimen set for HCV RNA: while 146 (71.6%) were core Ag positive, 168 (82.4%) had detectable HCV RNA, of which 96% were typeable as genotype 3 (39%), 1 (31%), or 6 (26%) by nested reverse transcription-PCR. Among RNA-positive specimens, 86.9% had core Ag; 94% of the RNA negatives were core Ag negative. While there was no apparent bias for detecting core Ag representing the tested genotypes, median quantified results were higher for types 1a and 6 than for genotype 3 (P = 0.01); similarly, the median core Ag concentration was higher in HCV-human immunodeficiency virus-coinfected subjects than in HCV-monoinfected subjects. Our results demonstrated a good correlation between core Ag and HCV RNA in this population with high frequencies of genotypes 3 and 6. Because most core Ag concentrations were greater than those in the measurable range, we recommend a 10-fold dilution of the specimen before quantification. Reproducibility, low technical requirements, and high throughput should make this assay useful for clinical or research monitoring of HCV levels during active infection.lld:pubmed
pubmed-article:15071017pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:languageenglld:pubmed
pubmed-article:15071017pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:citationSubsetIMlld:pubmed
pubmed-article:15071017pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15071017pubmed:statusMEDLINElld:pubmed
pubmed-article:15071017pubmed:monthAprlld:pubmed
pubmed-article:15071017pubmed:issn0095-1137lld:pubmed
pubmed-article:15071017pubmed:authorpubmed-author:ThomasDavid...lld:pubmed
pubmed-article:15071017pubmed:authorpubmed-author:MehtaShruti...lld:pubmed
pubmed-article:15071017pubmed:authorpubmed-author:SuriyanonVina...lld:pubmed
pubmed-article:15071017pubmed:authorpubmed-author:TicehurstJohn...lld:pubmed
pubmed-article:15071017pubmed:authorpubmed-author:WangXiao-Hong...lld:pubmed
pubmed-article:15071017pubmed:authorpubmed-author:CelentanoDavi...lld:pubmed
pubmed-article:15071017pubmed:authorpubmed-author:NelsonKenradKlld:pubmed
pubmed-article:15071017pubmed:authorpubmed-author:ManeekarnNiwa...lld:pubmed
pubmed-article:15071017pubmed:authorpubmed-author:ThongsawatSat...lld:pubmed
pubmed-article:15071017pubmed:authorpubmed-author:NetskiDale...lld:pubmed
pubmed-article:15071017pubmed:authorpubmed-author:Jittiwutikorn...lld:pubmed
pubmed-article:15071017pubmed:issnTypePrintlld:pubmed
pubmed-article:15071017pubmed:volume42lld:pubmed
pubmed-article:15071017pubmed:ownerNLMlld:pubmed
pubmed-article:15071017pubmed:authorsCompleteYlld:pubmed
pubmed-article:15071017pubmed:pagination1631-6lld:pubmed
pubmed-article:15071017pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:15071017pubmed:meshHeadingpubmed-meshheading:15071017...lld:pubmed
pubmed-article:15071017pubmed:meshHeadingpubmed-meshheading:15071017...lld:pubmed
pubmed-article:15071017pubmed:meshHeadingpubmed-meshheading:15071017...lld:pubmed
pubmed-article:15071017pubmed:meshHeadingpubmed-meshheading:15071017...lld:pubmed
pubmed-article:15071017pubmed:meshHeadingpubmed-meshheading:15071017...lld:pubmed
pubmed-article:15071017pubmed:meshHeadingpubmed-meshheading:15071017...lld:pubmed
pubmed-article:15071017pubmed:meshHeadingpubmed-meshheading:15071017...lld:pubmed
pubmed-article:15071017pubmed:meshHeadingpubmed-meshheading:15071017...lld:pubmed
pubmed-article:15071017pubmed:meshHeadingpubmed-meshheading:15071017...lld:pubmed
pubmed-article:15071017pubmed:meshHeadingpubmed-meshheading:15071017...lld:pubmed
pubmed-article:15071017pubmed:meshHeadingpubmed-meshheading:15071017...lld:pubmed
pubmed-article:15071017pubmed:meshHeadingpubmed-meshheading:15071017...lld:pubmed
pubmed-article:15071017pubmed:meshHeadingpubmed-meshheading:15071017...lld:pubmed
pubmed-article:15071017pubmed:meshHeadingpubmed-meshheading:15071017...lld:pubmed
pubmed-article:15071017pubmed:meshHeadingpubmed-meshheading:15071017...lld:pubmed
pubmed-article:15071017pubmed:meshHeadingpubmed-meshheading:15071017...lld:pubmed
pubmed-article:15071017pubmed:year2004lld:pubmed
pubmed-article:15071017pubmed:articleTitleHepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in thai injection drug users.lld:pubmed
pubmed-article:15071017pubmed:affiliationDepartment of Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland. dnetski1@jhmi.edulld:pubmed
pubmed-article:15071017pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15071017pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:15071017pubmed:publicationTypeEvaluation Studieslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15071017lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15071017lld:pubmed